​

Absci Stock (NASDAQ:ABSI)

ForecastRevenueOwnershipFinancialsChartTranscripts
Absci by TradingView

Previous Close

$2.46

52W Range

$2.01 - $6.33

50D Avg

$3.58

200D Avg

$3.66

Market Cap

$346.87M

Avg Vol (3M)

$4.76M

Beta

2.24

Div Yield

-

ABSI Company Profile

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

156

IPO Date

Jul 22, 2021

Website

ABSI Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceJun 21
Collaborative Revenue$136.00K
Technology Development Revenue$592.00K

Fiscal year ends in Dec 24 | Currency in USD

ABSI Financial Summary

Dec 24Dec 23Dec 22
Revenue$4.53M$5.72M$5.75M
Operating Income$-108.89M$-115.52M$-106.75M
Net Income$-103.11M$-110.57M$-104.90M
EBITDA$-90.35M$-95.46M$-91.36M
Basic EPS$-0.94$-1.20$-1.15
Diluted EPS$-0.94$-1.20$-1.15

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Mar 18, 25 | 4:30 PM
Q3 24Nov 12, 24 | 8:00 AM
Q2 24Aug 16, 24 | 4:30 PM

Peer Comparison

TickerCompany
HEPAHepion Pharmaceuticals, Inc.
AFMDAffimed N.V.
RXRXRecursion Pharmaceuticals, Inc.
RLAYRelay Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
DTILPrecision BioSciences, Inc.
SANASana Biotechnology, Inc.
XFORX4 Pharmaceuticals, Inc.
CRBUCaribou Biosciences, Inc.
INZYInozyme Pharma, Inc.
ELEVElevation Oncology, Inc.
ABOSAcumen Pharmaceuticals, Inc.
ZURAZura Bio Limited